|
The recruitment total for the trial to date is: | 54 |
Login using the investigator ID, password and PIN issued to you by the DASH trial office.
If you have forgotten your login details then please click here.
DASH-1 is now closed to randomisation.
Please continue to enter follow-up data and SAEs for existing
participants.
You are not logged in. Please ensure that your web browser has cookies enabled properly.
Please ensure that your web browser has both cookies and JavaScript enabled.
NOTE: |
Serious Adverse Events (SAEs) — we have a legal
responsibility to collect all SAEs occurring within the first
7 days (including SARs/SUSARs). Please remember that all fatal SAEs and safety outcome events – hyponatraemia (low sodium), hypervolaemia (fluid overload), seizures, VTE (DVT and/or PE), ischaemic stroke, TIA, MI/ACS and/or PAD – need to be reported, even those after the first 7 day period (until the final day 90 follow-up).
Please assess if expected according to SmPC:
https://medicines.org.uk/emc/product/5447/smpc
Investigators have a legal responsibility to report applicable SAEs
to the chief investigator within 24 hours.
|
|
|